Advertisement

Cardiol Therapeutics Inc. CRDL.TO

Set alert

Price alert · CRDL.TO

All alert types
1.62 CAD -0.04 -2.41%

As of Oct 30, 4:00 PM ET

1.55 Day range 1.65
1.28 52-week range 3.16
YTD
+23.66%
1 year
+5.88%
Open
1.65
Prev close
1.66
Mkt cap
196.85M
Vol
117.56K
Avg vol
251.10K
EPS
-0.34
P/E
0.00
Div yield
0.00%
More statistics
Low
1.55
High
1.65
Forward P/E
-4.19
Beta
0.70
Short ratio
2.22
Inst. own
9.51%
Dividend
0.00
Ex-div date
50-d avg
2.37
200-d avg
2.68
1y target
11.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 20, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Dec 18, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (98)
NameDateAgo
RSI: OversoldOct 30, 20261 day ago
MACD: Buy SignalOct 26, 20265 days ago
SMA: BearishOct 9, 20263 weeks ago
RSI: OversoldOct 2, 20264 weeks ago
MACD: Sell SignalSep 10, 20261 month ago
RSI: OverboughtSep 1, 20262 months ago
RSI: OverboughtAug 10, 20262 months ago
SMA: BullishJul 16, 20263 months ago
SMA: BullishJul 14, 20263 months ago
MACD: Buy SignalJun 22, 20264 months ago
SMA: BearishJun 8, 20264 months ago
SMA: BearishMay 27, 20265 months ago
SMA: BullishMay 20, 20265 months ago
SMA: BearishMay 19, 20265 months ago
MACD: Sell SignalApr 23, 20266 months ago
RSI: OverboughtApr 21, 20266 months ago
RSI: OverboughtMar 31, 20267 months ago
SMA: BullishMar 27, 20267 months ago
RSI: OverboughtMar 27, 20267 months ago
MACD: Buy SignalMar 25, 20267 months ago
SMA: BullishMar 24, 20267 months ago
MACD: Sell SignalMar 19, 20267 months ago
SMA: BearishMar 18, 20267 months ago
MACD: Buy SignalMar 11, 20267 months ago
SMA: BullishMar 10, 20267 months ago
SMA: BearishMar 5, 20268 months ago
SMA: BullishMar 4, 20268 months ago
SMA: BearishMar 3, 20268 months ago
MACD: Sell SignalMar 3, 20268 months ago
SMA: BullishMar 2, 20268 months ago
SMA: BearishFeb 27, 20268 months ago
MACD: Buy SignalFeb 26, 20268 months ago
MACD: Sell SignalFeb 23, 20268 months ago
SMA: BullishFeb 9, 20268 months ago
MACD: Buy SignalFeb 9, 20268 months ago
SMA: BearishFeb 5, 20268 months ago
MACD: Sell SignalJan 27, 20269 months ago
SMA: BearishJan 26, 20269 months ago
SMA: BullishJan 16, 20269 months ago
MACD: Buy SignalJan 16, 20269 months ago
MACD: Sell SignalJan 15, 20269 months ago
MACD: Buy SignalJan 6, 20269 months ago
MACD: Sell SignalDec 24, 202510 months ago
SMA: BearishDec 12, 202510 months ago
SMA: BullishDec 9, 202510 months ago
MACD: Buy SignalDec 8, 202510 months ago
SMA: BearishDec 1, 202511 months ago
MACD: Sell SignalDec 1, 202511 months ago
SMA: BullishNov 28, 202511 months ago
MACD: Buy SignalNov 25, 202511 months ago
SMA: BearishNov 4, 202512 months ago
SMA: BullishOct 31, 20251 year ago
MACD: Sell SignalOct 31, 20251 year ago
SMA: BearishOct 30, 20251 year ago
SMA: BearishOct 28, 20251 year ago
SMA: BullishOct 21, 20251 year ago
SMA: BullishOct 21, 20251 year ago
MACD: Buy SignalOct 20, 20251 year ago
MACD: Sell SignalOct 17, 20251 year ago
MACD: Buy SignalSep 11, 20251 year ago
MACD: Sell SignalSep 8, 20251 year ago
MACD: Buy SignalSep 5, 20251 year ago
MACD: Sell SignalAug 19, 20251 year ago
MACD: Buy SignalAug 18, 20251 year ago
SMA: BearishAug 15, 20251 year ago
SMA: BullishAug 14, 20251 year ago
MACD: Sell SignalAug 6, 20251 year ago
SMA: BearishAug 5, 20251 year ago
MACD: Buy SignalJul 24, 20251 year ago
SMA: BullishJul 22, 20251 year ago
SMA: BearishJul 15, 20251 year ago
MACD: Sell SignalJul 8, 20251 year ago
MACD: Buy SignalJul 3, 20251 year ago
MACD: Sell SignalJun 18, 20251 year ago
RSI: OverboughtJun 4, 20251 year ago
MACD: Buy SignalMay 28, 20251 year ago
SMA: BullishMay 22, 20251 year ago
SMA: BearishMay 21, 20251 year ago
MACD: Sell SignalMay 21, 20251 year ago
SMA: BullishMay 8, 20251 year ago
SMA: BearishMay 6, 20251 year ago
SMA: BullishMay 1, 20251 year ago
SMA: BearishApr 30, 20251 year ago
SMA: BullishApr 29, 20251 year ago
MACD: Buy SignalApr 14, 20251 year ago
RSI: OversoldApr 8, 20251 year ago
RSI: OversoldApr 4, 20251 year ago
MACD: Sell SignalMar 26, 20251 year ago
MACD: Buy SignalMar 13, 20251 year ago
MACD: Sell SignalFeb 12, 20251 year ago
SMA: BearishFeb 7, 20251 year ago
SMA: BullishFeb 4, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BullishJan 30, 20251 year ago
SMA: BearishJan 27, 20251 year ago
SMA: BullishJan 24, 20251 year ago
RSI: OversoldDec 23, 20241 year ago
RSI: OversoldDec 13, 20241 year ago

Key statistics

Market cap
146.89M
Enterprise value
153.64M
Trailing P/E
0.00
Forward P/E
-4.19
PEG ratio
0.00
Price / sales
0.00
Price / book
4.17
EPS (TTM)
-0.54
Beta
0.70
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-11.63M
Total cash
24.02M
Total debt
164.27K
Return on equity
-108.43%
Shares outstanding
81.60M
Short % of float
0.34%
50-day average
2.37
200-day average
2.68

Analyst view

Consensus: buy

Buy
Price target (mean) 11.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy4
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Upgrades / downgrades

CRDL.TO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 18, 2024HC Wainwright & Co.reitBuyBuy
Nov 20, 2024HC Wainwright & Co.reitBuyBuy
Oct 24, 2024HC Wainwright & Co.reitBuyBuy
Jun 26, 2024Roth MKMinit—Buy
Jun 14, 2024HC Wainwright & Co.reitBuyBuy
Jun 7, 2024HC Wainwright & Co.reitBuyBuy

About Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on CRDL.TO — it syncs with the Stock Master app.

Institution ownership

CRDL.TO institution ownership
Holder% heldSharesValueReported
Tejara Capital Ltd2.17%1,771,2703.19MSep 29, 2024
AdvisorShares Investments, LLC1.43%1,170,8692.11MSep 29, 2024
MMCAP International, Inc. SPC0.97%795,6251.43MSep 29, 2024
Lion Street Advisors, LLC0.33%273,281491.90KSep 29, 2024
Foundations Investment Advisors, Llc0.20%161,950291.51KSep 29, 2024
MGO One Seven, LLC0.12%100,000180.00KSep 29, 2024

Fund ownership

CRDL.TO fund ownership
Holder% heldSharesValueReported
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF1.28%1,047,2491.89MOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.06%52,43594.38KOct 30, 2024
Advertisement